Vaccinex, Inc.
ANTI-CCR8 ANTIBODIES AND USES THEREOF

Last updated:

Abstract:

The present disclosure is directed to antibodies or antigen-binding portions thereof that specifically bind human CCR8, polynucleotides and vectors encoding the same, and pharmaceutical compositions comprising the same. Some aspects of the disclosure are directed to methods of treating a disease or condition comprising administering the anti-CCR8 antibody to a subject in need thereof.

Status:
Application
Type:

Utility

Filling date:

6 Jan 2021

Issue date:

5 Aug 2021